How Daniel Faden, MD, and his team are working on developing and applying blood based cancer diagnostic tools.
Blog
Known as the “Alzheimer’s of the eye,” AMD affects nearly five million people across the world. How a new blood-based test could help.
Findings from a recent study, published in the New England Journal of Medicine, lend insight into a possible new eye screening protocol.